Mark Peplow's Critical point

  • 0815CW_CriticalPoint_630m

    Down to business

    28 July 2015

    To make the economic case for research, scientists need to understand how commercialisation works, says Mark Peplow

  • CW0715_CriticalPoint_630m

    Europe's science advice, redux

    24 June 2015

    Will a new expert panel be any more effective than a chief science adviser, wonders Mark Peplow

  • 0615CW-CriticalPoint-300tb

    Getting to know you

    1 June 2015

    The public does not fear chemists, it simply doesn’t know about them.

  • CW0515_CriticalPoint_630m

    An unfortunate oversight

    27 April 2015

    The US Toxic Substances Control Act is in dire need of reform. That demands compromises, says Mark Peplow

  • CW0415_Critical-point_630m

    Thinking ahead

    26 March 2015

    PhD courses must prepare students for a life after research, says Mark Peplow

  • DPA Picture Alliance / Alamy

    A large life, fully lived

    20 February 2015

    Carl Djerassi leaves many legacies besides the contraceptive pill,says Mark Peplow

  • 0215CW_Criticalpoint_630m

    The big experiment

    23 January 2015

    Plans to stop assessing school pupils’ practical work are the wrong solution to a genuine problem, says Mark Peplow

  • CW0115_Critical-point_300tb

    A bad business

    19 December 2014

    Targets and assessments can boost productivity at universities – but only if they do not stifle creativity and alienate the academic workforce, says Mark Peplow

  • CW1214_CriticalPoint_630m

    It's time to speak up for Europe

    27 November 2014

    Researchers in the UK benefit enormously from their country’s membership of the EU. They need to say so, argues Mark Peplow

  • CW1114_Critical-point_630m

    Two for the price of one

    23 October 2014

    This year’s Nobel prizes show that chemistry truly is the central science